AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

COLEFAX GROUP PLC

AGM Information Sep 13, 2018

7569_agm-r_2018-09-13_cd459d0f-07c0-4142-a403-b679adcfc5aa.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6127A

Colefax Group PLC

13 September 2018

AIM: CFX

13 September 2018

COLEFAX GROUP PLC

("Colefax" or "the Group")

AGM STATEMENT

Colefax will be holding its Annual General Meeting at 11am this morning and David Green, Chief Executive, will make the following comment on current trading:

"Since we announced our year end results in July the Group's sales have performed in line with expectations.

In the Group's core Fabric Division, sales in the US for the four months to 31 August increased by 4% on a constant currency basis. The US is our major market accounting for approximately 60% of Fabric Division sales. In the UK, sales for the four months to 31 August decreased by 3% and in Europe sales for the four months to 31 August decreased by 5% on a constant currency basis.

We have just entered our important autumn selling season and whilst we are optimistic about continued growth in the US, we expect trading conditions in the UK and Europe to remain relatively challenging."

Enquiries:

Colefax Group plc David Green, Chief Executive Tel: 020 7318 6000
Rob Barker, Finance Director
KTZ Communications Katie Tzouliadis  

Emma Pearson
Tel: 020 3178 6378
Peel Hunt LLP

(Nominated Advisor

And Broker)
Adrian Trimmings

George Sellar
Tel: 020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

AGMLTMFTMBIBBPP

Talk to a Data Expert

Have a question? We'll get back to you promptly.